Showing results (3111-3120 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|December 31, 2024
Q11, a CYP2E1 inhibitor, exerts anti-hepatocellular carcinoma effect by inhibiting M2 macrophage polarizationCunzhen Zhang, Yan Fang, Mengxue Guo, et al.
Cancer Immunology, Immunotherapy : CII|January 3, 2025
CMV IgG in the blood is not associated with hepatitis but correlates with poor outcomes in immunotherapy treated melanoma patientsSophia B Strobel, Devayani Machiraju, Melanie Wiecken, et al.
Cancer Immunology, Immunotherapy : CII|January 3, 2025
CCR5 and IL-12 co-expression in CAR T cells improves antitumor efficacy by reprogramming tumor microenvironment in solid tumorsYonggui Tian, Liubo Zhang, Yu Ping, et al.
Cancer Immunology, Immunotherapy : CII|January 3, 2025
Targeting immune checkpoints on myeloid cells: current status and future directionsChuhan Ma, Yang Li, Min Li, et al.
Cancer Immunology, Immunotherapy : CII|January 3, 2025
Prognostic relevance of CD163+ immune cells in patients with metastatic breast cancerIda Lindberg, Aya Saleh, Julia Tutzauer, et al.
Cancer Immunology, Immunotherapy : CII|January 3, 2025
Anti-PD1-/PDL1-induced chronic intestinal pseudo-obstruction: three cases treated with vedolizumab after corticosteroid failure with mixed resultsMorgan Zenatri, Michael Collins, Tifanie Alberto, et al.
Cancer Immunology, Immunotherapy : CII|January 3, 2025
Dual efficacy of tocilizumab in managing PD-1 inhibitors-induced myocardial inflammatory injury and suppressing tumor growth with PD-1 inhibitors: a preclinical studyYanxin Chen, Yuxi Luo, Yunwei Liu, et al.
Cancer Immunology, Immunotherapy : CII|January 4, 2024
PD-L1-positive circulating endothelial progenitor cells associated with immune response to PD-1 blockade in patients with head and neck squamous cell carcinomaNai-Wen Su, Shuen-Han Dai, Kate Hsu, et al.
Cancer Immunology, Immunotherapy : CII|January 4, 2024
Real-world outcomes of nivolumab plus ipilimumab and pembrolizumab with platinum-based chemotherapy in advanced non-small cell lung cancer: a multicenter retrospective comparative studyKinnosuke Matsumoto, Takayuki Shiroyama, Motohiro Tamiya, et al.
Cancer Immunology, Immunotherapy : CII|February 13, 2024
Longitudinal plasma proteomic analysis identifies biomarkers and combinational targets for anti-PD1-resistant cancer patientsQiaoyun Tan, Ruyun Gao, Xiaomei Zhang, et al.
Pageof 652